1
Clinical Trials associated with NNC0113-5840A First in Human Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of NNC0113-5840 in Participants With Overweight or Obesity
The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.
100 Clinical Results associated with NNC0113-5840
100 Translational Medicine associated with NNC0113-5840
100 Patents (Medical) associated with NNC0113-5840
100 Deals associated with NNC0113-5840